Ormiston M - Search Results

Year	Number of Results
1980	2
1981	2
1982	3
1985	5
1997	1
1998	1
2008	3
2009	4
2010	3
2011	2
2012	4
2013	3
2014	2
2015	7
2016	2
2017	6
2018	6
2019	5
2020	3
2021	1
2022	5
2023	3
2024	0

1

Pulmonary arterial hypertension: pathogenesis and clinical management.

Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Thenappan T, et al. Among authors: ormiston ml. BMJ. 2018 Mar 14;360:j5492. doi: 10.1136/bmj.j5492. BMJ. 2018. PMID: 29540357 Free PMC article. Review.

2

Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.

Long L, Ormiston ML, Yang X, Southwood M, Gräf S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, Moore SD, Drake KM, Aldred MA, Yu PB, Upton PD, Morrell NW. Long L, et al. Among authors: ormiston ml. Nat Med. 2015 Jul;21(7):777-85. doi: 10.1038/nm.3877. Epub 2015 Jun 15. Nat Med. 2015. PMID: 26076038 Free PMC article.

3

Legumain in Pulmonary Arterial Hypertension.

Hilton LR, Ormiston ML. Hilton LR, et al. Among authors: ormiston ml. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):536-537. doi: 10.1161/ATVBAHA.119.312430. Arterioscler Thromb Vasc Biol. 2019. PMID: 30917051 Free article. No abstract available.

4

Oh NO! Loss of PHD2 leads to "radical" changes in the lung vasculature.

Ormiston ML, Jankov RP, Stewart DJ. Ormiston ML, et al. Eur Respir J. 2022 Dec 22;60(6):2201776. doi: 10.1183/13993003.01776-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 36549689 No abstract available.

5

Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.

Cober ND, VandenBroek MM, Ormiston ML, Stewart DJ. Cober ND, et al. Among authors: ormiston ml. Hypertension. 2022 Aug;79(8):1580-1590. doi: 10.1161/HYPERTENSIONAHA.122.18261. Epub 2022 May 18. Hypertension. 2022. PMID: 35582968 Review.

6

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.

Karmouty-Quintana H, Guignabert C, Kwapiszewska G, Ormiston ML. Karmouty-Quintana H, et al. Among authors: ormiston ml. Front Physiol. 2018 Dec 10;9:1777. doi: 10.3389/fphys.2018.01777. eCollection 2018. Front Physiol. 2018. PMID: 30618793 Free PMC article. No abstract available.

7

Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?

VandenBroek MM, Skebo SI, Ormiston ML. VandenBroek MM, et al. Among authors: ormiston ml. Expert Opin Ther Targets. 2022 Dec;26(12):1027-1030. doi: 10.1080/14728222.2022.2168188. Epub 2023 Jan 18. Expert Opin Ther Targets. 2022. PMID: 36638064 No abstract available.

8

Mesenteric panniculitis.

Ormiston MC, Thomson H. Ormiston MC, et al. Postgrad Med J. 1980 Jan;56(651):67-8. doi: 10.1136/pgmj.56.651.67. Postgrad Med J. 1980. PMID: 7383957 Free PMC article.

9

Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer.

Harry JA, Ormiston ML. Harry JA, et al. Among authors: ormiston ml. Front Oncol. 2021 Dec 3;11:772305. doi: 10.3389/fonc.2021.772305. eCollection 2021. Front Oncol. 2021. PMID: 34926282 Free PMC article. Review.

10

The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.

Ormiston ML, Godoy RS, Chaudhary KR, Stewart DJ. Ormiston ML, et al. Circ Res. 2019 Mar 15;124(6):822-824. doi: 10.1161/CIRCRESAHA.119.314753. Circ Res. 2019. PMID: 30870124 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year